Literature DB >> 6955795

Pharmacokinetics of progesterone after its administration to ovariectomized rhesus monkeys by injection, infusion, or nasal spraying.

T C Anand Kumar, G F David, A Sankaranarayanan, V Puri, K R Sundram.   

Abstract

The pharmacokinetics of progesterone (dose: 10 microgram per animal) were studied in blood and cerebrospinal fluid of adult ovariectomized rhesus monkeys after the administration of the steroid as an intravenous injection, intravenous infusion (duration of infusion: 10 min), or nasal spray. The bioavailability of progesterone, in terms of area under the time--concentration curve and the maximal concentration in the two body fluids, was significantly higher when the steroid was infused or sprayed intranasally than when it was injected intravenously. The clearance of the steroid from the serum, as estimated by its elimination rate constant, elimination half-life, and total body clearance, did not differ for the three methods of administration. These findings suggest that the bioavailability of progesterone is enhanced by extending the duration over which the steroid is delivered into the hemic circulation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6955795      PMCID: PMC346602          DOI: 10.1073/pnas.79.13.4185

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  9 in total

1.  IGPHARM: interactive graphic package for pharmacokinetic analysis.

Authors:  C Gomeni; R Gomeni
Journal:  Comput Biomed Res       Date:  1978-08

2.  Ovulation in rhesus monkeys suppressed by intranasal administration of progesterone and norethisterone.

Authors:  T C Anand Kumar; G F David; V Puri
Journal:  Nature       Date:  1977-12-08       Impact factor: 49.962

3.  Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

Authors:  S Riegelman; J C Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

4.  The World Health Organization's programme for the standardization and quality control of radioimmunoassay of hormones in reproductive physiology.

Authors:  P E Hall
Journal:  Horm Res       Date:  1978

5.  Patterns of transfer of tritiated progesterone into blood & cerebrospinal fluid of rhesus monkeys following diverse methods of administration.

Authors:  A Sehgal; G F David; S K Dubey; T C Kumar
Journal:  Indian J Exp Biol       Date:  1980-07       Impact factor: 0.818

6.  Levels of estradiol and progesterone in the cerebrospinal fluid of rhesus monkey during the menstrual cycle.

Authors:  T C Kumar; G F David; V Puri
Journal:  J Med Primatol       Date:  1980       Impact factor: 0.667

7.  Association of tritium-labelled estradiol, progesterone and 17 alpha-hydroxyprogesterone with the proteins of the serum and cerebrospinal fluid in the rhesus monkey.

Authors:  B Umberkoman-Wiita; T C Anand Kumar
Journal:  Neuroendocrinology       Date:  1979       Impact factor: 4.914

8.  Selection and pairing of 'normal' rhesus monkeys (Macaca mulatta) for research: procedures, techniques, and observations.

Authors:  M J Kessler; J L Kupper; J D Grissett; R J Brown
Journal:  J Med Primatol       Date:  1979       Impact factor: 0.667

9.  Effects of intranasal administration of hormonal steroids on serum testosterone and spermatogenesis in rhesus monkey (Macaca mulatta).

Authors:  T C Anand Kumar; A Sehgal; G F David; J S Bajaj; M R Prasad
Journal:  Biol Reprod       Date:  1980-05       Impact factor: 4.285

  9 in total
  11 in total

1.  Enhancement of the systemic and CNS specific delivery of L-dopa by the nasal administration of its water soluble prodrugs.

Authors:  H D Kao; A Traboulsi; S Itoh; L Dittert; A Hussain
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

2.  Brain distribution and behavioral effects of progesterone and pregnenolone after intranasal or intravenous administration.

Authors:  Nicole Ducharme; William A Banks; John E Morley; Sandra M Robinson; Michael L Niehoff; Claudia Mattern; Susan A Farr
Journal:  Eur J Pharmacol       Date:  2010-06-08       Impact factor: 4.432

3.  Biovector nanoparticles improve antinociceptive efficacy of nasal morphine.

Authors:  D Betbeder; S Spérandio; J P Latapie; J de Nadai; A Etienne; J M Zajac; B Francés
Journal:  Pharm Res       Date:  2000-06       Impact factor: 4.200

4.  Nipecotic acid: systemic availability and brain delivery after nasal administration of nipecotic acid and n-butyl nipecotate to rats.

Authors:  Hongna Wang; Anwar A Hussain; Peter J Wedlund
Journal:  Pharm Res       Date:  2005-04-07       Impact factor: 4.200

5.  Localization and differential activity of P-glycoprotein in the bovine olfactory and nasal respiratory mucosae.

Authors:  Karunya K Kandimalla; Maureen D Donovan
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

Review 6.  A Historical Review of Brain Drug Delivery.

Authors:  William M Pardridge
Journal:  Pharmaceutics       Date:  2022-06-16       Impact factor: 6.525

7.  Inhaled turmerones can be incorporated in the organs via pathways different from oral administration and can affect weight-gain of mice.

Authors:  Yuki Takemoto; Chihiro Kishi; Hinano Ehira; Nobutaka Matsui; Taichi Yamaguchi; Yuri Yoshioka; Shinichi Matsumura; Tatsuya Moriyama; Nobuhiro Zaima
Journal:  Sci Rep       Date:  2022-06-30       Impact factor: 4.996

8.  Delivery of ziconotide to cerebrospinal fluid via intranasal pathway for the treatment of chronic pain.

Authors:  Prashanth Manda; Avadhesh Singh Kushwaha; Santanu Kundu; H N Shivakumar; Seong Bong Jo; S Narasimha Murthy
Journal:  J Control Release       Date:  2015-12-28       Impact factor: 9.776

9.  The effect of inhaled and oral dextromethorphan on citric acid induced cough in man.

Authors:  T J Grattan; A E Marshall; K S Higgins; A H Morice
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

Review 10.  Drug targeting to the brain.

Authors:  William M Pardridge
Journal:  Pharm Res       Date:  2007-06-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.